SCHEMBL16627356

SCHEMBL16627356

CC(=O)OC[C@@H](O)C(OC(C)=O)C(OC(C)=O)[C@H](COC(C)=O)OC(C)=O

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.79
ABCB1 P08183 1/20 0.43
MAPK1 P28482 2/20 0.42
POLB P06746 1/20 0.42
ALDH1A1 P00352 3/20 0.32
LMNA P02545 2/20 0.32
HSD17B10 Q99714 1/20 0.32
TSHR P16473 1/20 0.32
PRKCA P17252 1/20 0.32
TRPV1 Q8NER1 1/20 0.32
USP2 O75604 3/20 0.31
CYP3A4 P08684 3/20 0.31
MAPT P10636 3/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
RECQL P46063 1/20 0.31
PGD P52209 1/20 0.31
HPGD P15428 1/20 0.30
MEN1 O00255 1/20 0.30
TP53 P04637 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17635918 1.00 TDP1 (0.79) TDP1ABCB1MAPK1POLBALDH1A1
SCHEMBL13625312 0.94 TDP1 (0.75) TDP1ABCB1MAPK1POLBALDH1A1
SCHEMBL2175855 0.90 TDP1 (0.96) TDP1ABCB1MAPK1POLBALDH1A1
SCHEMBL270042 0.90 TDP1 (0.96) TDP1ABCB1MAPK1POLBALDH1A1
SCHEMBL7152317 0.90 TDP1 (0.96) TDP1ABCB1MAPK1POLBALDH1A1
SCHEMBL826717 0.90 TDP1 (0.96) TDP1ABCB1MAPK1POLBALDH1A1
SCHEMBL7150717 0.90 TDP1 (0.96) TDP1ABCB1MAPK1POLBALDH1A1
SCHEMBL7149374 0.90 TDP1 (0.96) TDP1ABCB1MAPK1POLBALDH1A1
SCHEMBL13168216 0.90 TDP1 (0.96) TDP1ABCB1MAPK1POLBALDH1A1
SCHEMBL16638483 0.89 TDP1 (0.73) TDP1ABCB1MAPK1POLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9005578-B2 Compounds and compositions for the detection and treatment of Alzheimer's disease and related disorders FLUOROPHARMA, INC. (US) 2015-04-14 US disclosed
US-20150098903-A1 Compounds and Compositions for the Detection and Treatment of Alzheimer's Disease and Related Disorders THE GENERAL HOSPITAL CORPORATION 2015-04-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150098903-A1 Compounds and Compositions for the Detection and Treatment of Alzheimer's Disease and Related Disorders APP, PSEN1, PSEN2 TDP1 1128/4885ABCB1 305/4885MAPK1 4002/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.